Drug information for BRAVELLE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INTRAMUSCULAR, SUBCUTANEOUS
75 IU/VIAL
Prescription
(Reference Drug)
UROFOLLITROPIN
Urofollitropin
FERRING
21289
2002-05-06 Review
2002-05-06 Letter
2002-05-06 Label
Injectable; Subcutaneous
0.9%
Prescription
UROFOLLITROPIN
Urofollitropin
FERRING
21484
2004-05-28 Letter
2003-05-08 Review
2003-04-09 Label
Drug Adverse Effects information for BRAVELLE
Role code
Indications
Reaction
# Reports
PS
IN VITRO FERTILISATION
ABORTION SPONTANEOUS
2
PS
IN VITRO FERTILISATION
MATERNAL EXPOSURE DURING PREGNANCY
2
C
PRODUCT USED FOR UNKNOWN INDICATION
ABDOMINAL DISTENSION
8
C
PRODUCT USED FOR UNKNOWN INDICATION
ABDOMINAL PAIN
8
C
PRODUCT USED FOR UNKNOWN INDICATION
GESTATIONAL DIABETES
8
C
PRODUCT USED FOR UNKNOWN INDICATION
HAEMORRHAGE
8
C
PRODUCT USED FOR UNKNOWN INDICATION
HEADACHE
8
C
PRODUCT USED FOR UNKNOWN INDICATION
MUSCLE SPASMS
8
C
PRODUCT USED FOR UNKNOWN INDICATION
OVULATION DISORDER
8
Ads by Google